Table 1.

¹⁸FLT-PET and drug characteristics

Patient #	MTV (cc)	ΔSUVmax	ΔSUVmean	Everolimus Peak	Everolimus Trough
1	70.1	−27%	−19%	33.50	0.00
2	40.2	−10%	0%	53.10	2.50
3	16	−14%	0%	55.10	1.60
4	20	−38%	−17%	43.20	1.90
5	27.4	−28%	−7%	23.90	0.00
6	27.2	−42%	−13%	33.80	14.80
7	9.6	−15%	0%	15.90	0.00
8	33.8	–	–	–	–
9	22.4	0%	0%	–	–
10	19.5	–	–	–	–
11	40.2	12%	8%	–	–

Drug level 1 is 24 h after the first everolimus dose. Drug level 2 is 1 h before the second everolimus dose (ng/mL).